Aridis Pharmaceuticals, Inc. (ARDS)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Mar 31, 2025

Aridis Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2022 FY 2021 FY 2020 FY 2019 FY 2018 2015 - 2017
Period Ending
Mar '25 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 2015 - 2017
Market Capitalization
02933614090
Upgrade
Market Cap Growth
-72.36%-10.24%-46.41%54.06%-55.88%-
Upgrade
Enterprise Value
54215562256
Upgrade
Last Close Price
0.001.182.336.074.4511.09
Upgrade
PS Ratio
0.009.5121.3361.1038.8132.60
Upgrade
PB Ratio
-0.39-1.21-2.50-7.0410.913.42
Upgrade
P/TBV Ratio
----11.003.42
Upgrade
EV/Sales Ratio
0.2213.459.4655.6021.8520.24
Upgrade
Debt / Equity Ratio
-0.41-0.25-0.46-0.08--
Upgrade
Asset Turnover
2.400.150.070.050.030.10
Upgrade
Quick Ratio
0.030.170.550.381.104.97
Upgrade
Current Ratio
0.240.320.730.571.345.35
Upgrade
Return on Equity (ROE)
-----198.20%-89.10%
Upgrade
Return on Assets (ROA)
-4.40%-89.68%-127.38%-64.99%-61.03%-51.90%
Upgrade
Return on Capital (ROIC)
-----121.40%-60.76%
Upgrade
Earnings Yield
-21417.85%-103.33%-128.85%-36.55%-74.84%-24.59%
Upgrade
FCF Yield
-336346.59%-99.38%-71.66%-34.11%-21.01%-27.76%
Upgrade
Buyback Yield / Dilution
-88.34%-52.77%-34.06%-8.40%-168.80%-1791.31%
Upgrade
Updated Nov 6, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.